Hansoh Pharmaceutical Regains Rights to Ameile After EQRx Partnership Cancellation
Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced the cancellation of its partnership and...
Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced the cancellation of its partnership and...
US-based EQRx Inc. (NASDAQ: EQRX) has revealed that a definitive agreement has been signed for...
CStone Pharmaceuticals (HKG: 2616) has officially responded to recent news reports regarding the suspension of...